申请人:PFIZER
公开号:WO2009106980A2
公开(公告)日:2009-09-03
This invention relates to compounds, pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a therapeutically effective amount of the compound of Formula (I): wherein R1, R2 and R3 are as defined in this specification.